XML 132 R117.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidating Financial Information (Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash Flow from Operating Activities:      
Net cash provided by operating activities $ 381,042 $ (28,028) $ 142,157
Cash Flow from Investing Activities:      
Acquisition of SoberLink, cash consideration 0 0 (24,402)
Acquisition of CEC, cash consideration, net of cash acquired (353,556) 0 0
Proceeds from sale of property and equipment 3,460 2,030 42
Acquisition of LCS, cash consideration 0 0 (307,404)
Insurance proceeds - damaged property 2,754 4,733 1,270
Change in restricted cash and investments (33,661) (9,558) (4,805)
Capital expenditures (148,406) (81,565) (117,581)
Net cash used in investing activities (529,409) (84,360) (452,880)
Cash Flow from Financing Activities:      
Payments on long-term debt (1,140,788) (934,006) (311,985)
Proceeds from long term debt 1,389,084 1,012,945 724,798
Payments on non-recourse debt (307,414) (10,064) (11,908)
Proceeds from non-recourse debt 181,658 266,835 123,560
Taxes paid related to net share settlements of equity awards (4,142) (2,336) (2,786)
Tax benefit (deficiency) related to equity compensation 0 (1,626) 1,409
Debt issuance costs (9,542) (21,115) (7,069)
Proceeds from stock options exercised 6,962 3,347 2,774
Dividends paid (227,463) (194,748) (186,984)
Proceeds from issuance of common stock in connection with ESPP 497 436 441
Issuance of common stock in connection with public offering 275,867 0 0
Net cash provided by financing activities 164,719 119,668 332,250
Effect of Exchange Rate Changes on Cash and Cash Equivalents (3,013) 1,120 (3,226)
Net Increase in Cash and Cash Equivalents 13,339 8,400 18,301
Cash and Cash Equivalents, beginning of period 68,038 59,638 41,337
Cash and Cash Equivalents, end of period 81,377 68,038 59,638
The GEO Group Inc.      
Cash Flow from Operating Activities:      
Net cash provided by operating activities 118,180 154,125 153,861
Cash Flow from Investing Activities:      
Acquisition of SoberLink, cash consideration    
Acquisition of CEC, cash consideration, net of cash acquired (353,556)    
Proceeds from sale of property and equipment 3,436 2,030 0
Acquisition of LCS, cash consideration     (307,404)
Insurance proceeds - damaged property 2,754 0 0
Change in restricted cash and investments 0 (24) 90
Capital expenditures (53,030) (14,040) (55,629)
Net cash used in investing activities (400,396) (12,034) (362,943)
Cash Flow from Financing Activities:      
Payments on long-term debt (1,140,788) (934,006) (311,985)
Proceeds from long term debt 1,389,084 1,012,945 724,798
Payments on non-recourse debt 0 0 0
Proceeds from non-recourse debt 0 0 0
Taxes paid related to net share settlements of equity awards (4,142) (2,336) (2,786)
Tax benefit (deficiency) related to equity compensation   (844) 1,409
Debt issuance costs (8,701) (16,980) 0
Proceeds from stock options exercised 6,962 2,367 2,774
Dividends paid (227,463) (194,748) (186,984)
Proceeds from issuance of common stock in connection with ESPP 497 0 441
Issuance of common stock in connection with public offering 275,867    
Net cash provided by financing activities 291,316 (133,602) 227,667
Effect of Exchange Rate Changes on Cash and Cash Equivalents 0 0 0
Net Increase in Cash and Cash Equivalents 9,100 8,489 18,585
Cash and Cash Equivalents, beginning of period 45,566 37,077 18,492
Cash and Cash Equivalents, end of period 54,666 45,566 37,077
Combined Subsidiary Guarantors      
Cash Flow from Operating Activities:      
Net cash provided by operating activities 91,467 66,009 84,795
Cash Flow from Investing Activities:      
Acquisition of SoberLink, cash consideration     (24,402)
Acquisition of CEC, cash consideration, net of cash acquired 0    
Proceeds from sale of property and equipment 0 0 42
Acquisition of LCS, cash consideration     0
Insurance proceeds - damaged property 0 0 1,270
Change in restricted cash and investments (5,973) (3,356) (2,658)
Capital expenditures (86,336) (61,811) (59,829)
Net cash used in investing activities (92,309) (65,167) (85,577)
Cash Flow from Financing Activities:      
Payments on long-term debt 0 0  
Proceeds from long term debt 0 0 0
Payments on non-recourse debt 0 0 0
Proceeds from non-recourse debt 0 0 0
Taxes paid related to net share settlements of equity awards 0 0 0
Tax benefit (deficiency) related to equity compensation   0 0
Debt issuance costs 0 0 0
Proceeds from stock options exercised 0 0 0
Dividends paid 0 0
Proceeds from issuance of common stock in connection with ESPP 0   0
Issuance of common stock in connection with public offering 0    
Net cash provided by financing activities 0 0 0
Effect of Exchange Rate Changes on Cash and Cash Equivalents 0 0 0
Net Increase in Cash and Cash Equivalents (842) 842 (782)
Cash and Cash Equivalents, beginning of period 842 0 782
Cash and Cash Equivalents, end of period 0 842 0
Combined Non-Guarantor Subsidiaries      
Cash Flow from Operating Activities:      
Net cash provided by operating activities 171,395 (248,162) (96,499)
Cash Flow from Investing Activities:      
Acquisition of SoberLink, cash consideration    
Acquisition of CEC, cash consideration, net of cash acquired 0    
Proceeds from sale of property and equipment 24 0 0
Acquisition of LCS, cash consideration     0
Insurance proceeds - damaged property 0 4,733 0
Change in restricted cash and investments (27,688) (6,178) (2,237)
Capital expenditures (9,040) (5,714) (2,123)
Net cash used in investing activities (36,704) (7,159) (4,360)
Cash Flow from Financing Activities:      
Payments on long-term debt 0 0 0
Proceeds from long term debt 0 0 0
Payments on non-recourse debt (307,414) (10,064) (11,908)
Proceeds from non-recourse debt 181,658 266,835 123,560
Taxes paid related to net share settlements of equity awards 0 0 0
Tax benefit (deficiency) related to equity compensation   (782) 0
Debt issuance costs (841) (4,135) (7,069)
Proceeds from stock options exercised 0 980 0
Dividends paid 0 0 0
Proceeds from issuance of common stock in connection with ESPP 0 436 0
Issuance of common stock in connection with public offering 0    
Net cash provided by financing activities (126,597) 253,270 104,583
Effect of Exchange Rate Changes on Cash and Cash Equivalents (3,013) 1,120 (3,226)
Net Increase in Cash and Cash Equivalents 5,081 (931) 498
Cash and Cash Equivalents, beginning of period 21,630 22,561 22,063
Cash and Cash Equivalents, end of period $ 26,711 $ 21,630 $ 22,561